Clonal Heterogeneity of Acute Myeloid Leukemia Treated with the IDH2 inhibitor Enasidenib

Vyas P., Quek L., David M., Kennedy A., Metzner M., Amatangelo M., Shih A., Stoilova B., Quivoron C., Heiblig M., Willekens C., Saada V., Alsafadi S., Vijayabaskar M., Peniket A., Bernard O., Agresta S., Yen K., MacBeth K., Stein E., Vassiliou G., Levine R., De Botton S., Thakurta A., Penard-Lacronique V.

Type

Journal article

Journal

Nature Medicine

Publisher

Nature Publishing Group

Publication Date

16/07/2018

Permalink